| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| EHTHeHealth, Inc. | 118.14M | 3.84 | -3.23 | 17.56% | 9.27% | 5.69% | 0.16 |
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 189.54M | 193.32M | 190.71M | 251.4M | 506.2M | 582.77M | 538.2M | 405.36M | 452.87M | 532.41M |
| Revenue Growth % | 0.05% | 0.02% | -0.01% | 0.32% | 1.01% | 0.15% | -0.08% | -0.25% | 0.12% | 0.18% |
| Medical Costs & Claims | 4.18M | 862K | 582K | 1.23M | 2.74M | 4.08M | 1.99M | 1.65M | 1.77M | 1.79M |
| Medical Cost Ratio % | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | 185.36M | 192.46M | 190.12M | 250.17M | 503.46M | 578.69M | 536.21M | 403.71M | 451.1M | 530.62M |
| Gross Margin % | - | - | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | 0.06% | 0.04% | -0.01% | 0.32% | 1.01% | 0.15% | -0.07% | -0.25% | 0.12% | 0.18% |
| Operating Expenses | 191.01M | 189.64M | 199.58M | 247.62M | 422.05M | 525.37M | 661.85M | 506.42M | 480.17M | 507.05M |
| OpEx / Revenue % | - | - | - | - | - | - | - | - | - | - |
| Depreciation & Amortization | 5.93M | 5.51M | 5.34M | 6.77M | 8.99M | 12.94M | 18.87M | 21.11M | 19.92M | 16.34M |
| Combined Ratio % | - | - | - | - | - | - | - | - | - | - |
| Operating Income | -5.65M | 2.82M | -9.45M | 2.55M | 81.41M | 53.32M | -125.64M | -102.71M | -29.07M | 23.57M |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - |
| Operating Income Growth % | 0.16% | 1.5% | -4.35% | 1.27% | 30.91% | -0.34% | -3.36% | 0.18% | 0.72% | 1.81% |
| EBITDA | 277K | 8.34M | -4.11M | 9.32M | 90.4M | 66.27M | -106.78M | -81.61M | -9.16M | 39.91M |
| EBITDA Margin % | - | - | - | - | - | - | - | - | - | - |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 845K | 7.63M | 10.97M | 11.16M |
| Non-Operating Income | -4.54M | 297K | -621K | -14.24M | -24.08M | 0 | -1.6M | -3.95M | -9.45M | -6.9M |
| Pretax Income | -5.61M | 3.97M | -8.27M | 3.31M | 83.5M | 53.99M | -124.89M | -106.39M | -30.59M | 19.31M |
| Pretax Margin % | - | - | - | - | - | - | - | - | - | - |
| Income Tax | -843K | 3.67M | -33.7M | 3.06M | 16.61M | 8.54M | -20.52M | -17.67M | -2.38M | 9.26M |
| Effective Tax Rate % | - | - | - | - | - | - | - | - | - | - |
| Net Income | -4.76M | 304K | 25.43M | 241K | 66.89M | 45.45M | -104.38M | -88.72M | -28.21M | 10.06M |
| Net Margin % | - | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | 0.71% | 1.06% | 82.64% | -0.99% | 276.54% | -0.32% | -3.3% | 0.15% | 0.68% | 1.36% |
| EPS (Diluted) | -0.26 | -0.27 | 1.33 | 0.01 | 2.73 | 1.68 | -3.90 | -4.36 | -2.37 | -1.19 |
| EPS Growth % | 0.7% | -0.04% | 5.93% | -0.99% | 230.36% | -0.38% | -3.32% | -0.12% | 0.46% | 0.5% |
| EPS (Basic) | -0.26 | -0.27 | 1.37 | 0.01 | 2.90 | 1.75 | -3.90 | -4.36 | -2.37 | -1.19 |
| Diluted Shares Outstanding | 18.01M | 18.27M | 19.05M | 20.41M | 24.54M | 27.01M | 26.78M | 27.36M | 28.02M | 29.34M |
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | 113.32M | 108.9M | 359.12M | 439.28M | 741.63M | 1.04B | 1.15B | 1.11B | 1.11B | 1.16B |
| Asset Growth % | 0.06% | -0.04% | 2.3% | 0.22% | 0.69% | 0.4% | 0.11% | -0.03% | 0% | 0.04% |
| Total Investment Assets | -204K | -204K | 170.3M | 211.44M | 0 | 49.62M | 41.31M | 0 | 5.93M | 43.04M |
| Long-Term Investments | -204K | -204K | 170.3M | 211.44M | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 49.62M | 41.31M | 0 | 5.93M | 43.04M |
| Total Current Assets | 77.54M | 76.14M | 155.74M | 156.17M | 208.15M | 330.99M | 407.59M | 401.08M | 382.35M | 354.48M |
| Cash & Equivalents | 62.71M | 61.78M | 40.29M | 13.09M | 23.47M | 43.76M | 81.93M | 144.4M | 115.72M | 39.2M |
| Receivables | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K |
| Other Current Assets | 2.79M | 2.21M | 1.56M | 2.87M | 260K | 646K | 922K | 223K | 733K | 1.32M |
| Goodwill & Intangibles | 23.72M | 22.68M | 21.64M | 52.48M | 50.3M | 48.8M | 1.92M | 0 | 23.6M | 0 |
| Goodwill | 14.1M | 14.1M | 14.1M | 40.23M | 40.23M | 40.23M | 0 | 0 | 0 | 0 |
| Intangible Assets | 9.62M | 8.58M | 7.54M | 12.25M | 10.06M | 8.57M | 1.92M | 0 | 23.6M | 0 |
| PP&E (Net) | 7.36M | 5.61M | 4.71M | 7.68M | 47.14M | 57.17M | 49.48M | 32.02M | 27.63M | 16.52M |
| Other Assets | 4.7M | 4.47M | 6.51M | 11.28M | 435.79M | 603.06M | 690.3M | 679.51M | 679.76M | 784.43M |
| Total Liabilities | 36.9M | 31.3M | 72.45M | 136.13M | 214.47M | 202.46M | 399.77M | 461.66M | 209.26M | 567M |
| Total Debt | 0 | 2.01M | 3.39M | 5M | 39.06M | 46.56M | 41.37M | 106.8M | 103.16M | 96.92M |
| Net Debt | -62.71M | -59.77M | -36.9M | -8.09M | 15.6M | 2.8M | -40.56M | -37.6M | -12.56M | 57.72M |
| Long-Term Debt | 0 | 0 | 0 | 5M | 0 | 0 | 0 | 66.13M | 67.75M | 68.46M |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Current Liabilities | 31.94M | 27.92M | 25.45M | 60.62M | 112.98M | 84.41M | 75.47M | 60.56M | 78.54M | 96.01M |
| Accounts Payable | 3.01M | 5.11M | 3.25M | 5.69M | 24.55M | 36.92M | 13.75M | 6.73M | 7.2M | 23.45M |
| Deferred Revenue | 392K | 959K | 385K | 876K | 2.57M | 308K | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 0 | 0 | 0 | 23.16M | 69.06M | 24.2M | 19.79M | 23.58M | 43.93M | 48.22M |
| Deferred Taxes | 329K | 443K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 0 | 1000K |
| Other Liabilities | 4.63M | 2.93M | 1.92M | 22.61M | 3.05M | 4.37M | 237.69M | 268.42M | 34.64M | 342.93M |
| Total Equity | 76.42M | 15.82M | 246.37M | 295.06M | 527.16M | 837.56M | 749.52M | 650.96M | 904.08M | 588.43M |
| Equity Growth % | 0.04% | -0.79% | 14.57% | 0.2% | 0.79% | 0.59% | -0.11% | -0.13% | 0.39% | -0.35% |
| Shareholders Equity | 76.42M | 77.6M | 286.66M | 303.15M | 527.16M | 837.56M | 749.52M | 650.96M | 904.08M | 588.43M |
| Minority Interest | 0 | -61.78M | -40.29M | -8.09M | 0 | 0 | 0 | 0 | 0 | 0 |
| Retained Earnings | 9.5M | 4.62M | 204.72M | 204.97M | 271.85M | 316.15M | 193.21M | 73.8M | 7.28M | 15.25M |
| Common Stock | 29K | 29K | 30K | 31K | 35K | 38K | 39K | 40K | 41K | 43K |
| Accumulated OCI | 193K | 176K | 202K | 127K | 116K | 350K | 390K | -73K | -82K | -234K |
| Return on Equity (ROE) | -0.06% | 0.01% | 0.19% | 0% | 0.16% | 0.07% | -0.13% | -0.13% | -0.04% | 0.01% |
| Return on Assets (ROA) | -0.04% | 0% | 0.11% | 0% | 0.11% | 0.05% | -0.1% | -0.08% | -0.03% | 0.01% |
| Equity / Assets | - | - | - | - | - | - | - | - | - | - |
| Debt / Equity | - | 0.13x | 0.01x | 0.02x | 0.07x | 0.06x | 0.06x | 0.16x | 0.11x | 0.16x |
| Book Value per Share | 4.24 | 0.87 | 12.93 | 14.46 | 21.48 | 31.00 | 27.99 | 23.79 | 32.27 | 20.06 |
| Tangible BV per Share | - | - | - | - | - | - | - | - | - | - |
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | 13.7M | 4.08M | -15.54M | -3.23M | -71.49M | -107.86M | -162.62M | -26.87M | -6.69M | -18.37M |
| Operating CF Growth % | 6.7% | -0.7% | -4.81% | 0.79% | -21.13% | -0.51% | -0.51% | 0.83% | 0.75% | -1.74% |
| Operating CF / Revenue % | - | - | - | - | - | - | - | - | - | - |
| Net Income | -4.76M | -4.88M | 25.43M | 241K | 66.89M | 45.45M | -104.38M | -88.72M | -28.21M | 10.06M |
| Depreciation & Amortization | 5.93M | 5.51M | 5.34M | 6.77M | 8.99M | 12.94M | 18.87M | 21.11M | 19.92M | 16.34M |
| Stock-Based Compensation | 7M | 7.27M | 9.69M | 12.54M | 22.57M | 25.17M | 32.86M | 20.32M | 23.21M | 19.88M |
| Deferred Taxes | 101K | 114K | -30.34M | 2.81M | 16.2M | 8.82M | -21.52M | -18.44M | -2.67M | 9.18M |
| Other Non-Cash Items | 2.11M | 1.42M | -101K | 12.97M | 23.32M | 1.09M | 47.81M | 14.19M | 701K | 7.91M |
| Working Capital Changes | 3.32M | -5.35M | -25.56M | -38.57M | -209.46M | -201.33M | -136.26M | 24.68M | -19.64M | -81.73M |
| Cash from Investing | -3M | -3.73M | -5.08M | -25.76M | -16.94M | -73.28M | -12.63M | 25.86M | -15.89M | -48.42M |
| Capital Expenditures | -3M | -3.73M | -5.08M | -10.83M | -16.87M | -23.76M | -20.86M | -15.51M | -2.09M | 0 |
| Acquisitions | 0 | 0 | 0 | -14.93M | 0 | 16M | 16.99M | 15.51M | 0 | 0 |
| Purchase of Investments | 0 | 0 | 0 | 0 | 0 | -180.5M | -103.06M | -8.4M | -54.51M | -96.98M |
| Sale/Maturity of Investments | 0 | 0 | 0 | 0 | 0 | 1000K | 1000K | 1000K | 1000K | 1000K |
| Other Investing | -1.12M | -1.84M | -3.21M | -6.29M | -72K | -16M | -16.99M | -15.51M | -8.69M | -12.86M |
| Cash from Financing | 577K | -1.27M | -870K | 1.86M | 102.14M | 201.25M | 213.24M | 63.84M | -6.22M | -9.67M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -3.53M | -5.56M |
| Share Repurchases | -922K | -1.25M | -1.8M | -4.5M | -14.28M | -19.81M | -9.33M | -3.1M | -3.33M | -3.41M |
| Stock Issued | 0 | 0 | 0 | 0 | 126.05M | 228.02M | 0 | 0 | 0 | 0 |
| Debt Issuance (Net) | -73K | -83K | -105K | 1000K | -1000K | -157K | -150K | 1000K | -38K | -4K |
| Other Financing | 1.57M | 62K | 1.04M | 1.47M | -4.52M | -6.81M | 8.7M | 2.21M | 677K | -696K |
| Net Change in Cash | 11.29M | -929K | -21.49M | -27.2M | 13.73M | 20.29M | 38.05M | 62.48M | -28.83M | -76.53M |
| Exchange Rate Effect | 18K | -17K | 1K | -77K | 26K | 187K | 64K | -355K | -19K | -64K |
| Cash at Beginning | 51.41M | 62.71M | 61.78M | 40.29M | 13.09M | 26.82M | 47.11M | 85.17M | 147.64M | 118.81M |
| Cash at End | 62.71M | 61.78M | 40.29M | 13.09M | 26.82M | 47.11M | 85.17M | 147.64M | 118.81M | 42.29M |
| Free Cash Flow | 10.7M | 357K | -20.62M | -14.06M | -88.36M | -131.62M | -183.48M | -42.38M | -17.47M | -31.22M |
| FCF Growth % | 2.69% | -0.97% | -58.76% | 0.32% | -5.29% | -0.49% | -0.39% | 0.77% | 0.59% | -0.79% |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - |
| FCF per Share | 0.59 | 0.02 | -1.08 | -0.69 | -3.6 | -4.87 | -6.85 | -1.55 | -0.62 | -1.06 |
| Metric | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Combined Ratio | 102.98% | 98.54% | 104.96% | 98.99% | 83.92% | 90.85% | 123.35% | 125.34% | 106.42% | 95.57% |
| Medical Cost Ratio | 2.2% | 0.45% | 0.31% | 0.49% | 0.54% | 0.7% | 0.37% | 0.41% | 0.39% | 0.34% |
| Return on Equity (ROE) | -6.35% | 0.66% | 19.39% | 0.09% | 16.27% | 6.66% | -13.15% | -12.67% | -3.63% | 1.35% |
| Return on Assets (ROA) | -4.33% | 0.27% | 10.87% | 0.06% | 11.33% | 5.1% | -9.54% | -7.84% | -2.54% | 0.89% |
| Equity / Assets | 67.44% | 14.53% | 68.6% | 67.17% | 71.08% | 80.53% | 65.22% | 58.51% | 81.2% | 50.93% |
| Book Value / Share | 4.24 | 0.87 | 12.93 | 14.46 | 21.48 | 31 | 27.99 | 23.79 | 32.27 | 20.06 |
| Debt / Equity | - | 0.13x | 0.01x | 0.02x | 0.07x | 0.06x | 0.06x | 0.16x | 0.11x | 0.16x |
| Revenue Growth | 5.49% | 2% | -1.35% | 31.82% | 101.36% | 15.13% | -7.65% | -24.68% | 11.72% | 17.56% |
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|
| Commission | - | - | - | 466.68M | - | - | - | 403.92M | 461.65M |
| Commission Growth | - | - | - | - | - | - | - | - | 14.29% |
| Medicare | - | - | - | - | 436.42M | 425.5M | 318.15M | 360.85M | 427.35M |
| Medicare Growth | - | - | - | - | - | -2.50% | -25.23% | 13.42% | 18.43% |
| Product and Service, Other | - | - | - | 39.52M | 74.58M | 45.08M | 44.11M | 48.95M | 70.76M |
| Product and Service, Other Growth | - | - | - | - | 88.70% | -39.56% | -2.15% | 10.97% | 44.57% |
| Small Business | - | - | - | - | 9.57M | 10.72M | 11.84M | 17.67M | 11.54M |
| Small Business Growth | - | - | - | - | - | 12.04% | 10.47% | 49.21% | -34.66% |
| Ancillaries | - | - | - | - | 27.14M | 21.35M | 11.47M | 10.75M | 10.79M |
| Ancillaries Growth | - | - | - | - | - | -21.31% | -46.31% | -6.21% | 0.31% |
| Individual and Family | - | - | - | - | 26.67M | 32.87M | 17.86M | 16.66M | 8.4M |
| Individual and Family Growth | - | - | - | - | - | 23.27% | -45.66% | -6.75% | -49.57% |
| Commission Bonus | - | - | - | - | 8.4M | 2.67M | 1.92M | -2.01M | 3.56M |
| Commission Bonus Growth | - | - | - | - | - | -68.21% | -28.05% | -204.79% | 277.05% |
| Medicare | 80.27M | 102.58M | 210.57M | - | - | - | - | - | - |
| Medicare Growth | - | 27.80% | 105.27% | - | - | - | - | - | - |
| Individual, Family, And Small Businesss | 106.69M | 69.77M | 40.83M | - | - | - | - | - | - |
| Individual, Family, And Small Businesss Growth | - | -34.60% | -41.49% | - | - | - | - | - | - |
eHealth, Inc. (EHTH) grew revenue by 17.6% over the past year. This is strong growth.
Yes, eHealth, Inc. (EHTH) is profitable, generating $50.3M in net income for fiscal year 2024 (1.9% net margin).
Yes, eHealth, Inc. (EHTH) pays a dividend with a yield of 4.94%. This makes it attractive for income-focused investors.
eHealth, Inc. (EHTH) has a return on equity (ROE) of 1.3%. This is below average, suggesting room for improvement.
eHealth, Inc. (EHTH) has a combined ratio of 95.6%. A ratio below 100% indicates underwriting profitability.